Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers

Walter Mazzucco, Claudia Marotta, Stefania Boccia, Paolo Villari, Colotto, Walter Ricciardi, Walter Mazzucco, Carolina Marzuillo, Roberta Pastorino, D'Andrea, Antonio Federici, Lagerberg, Marotta

Risultato della ricerca: Article

9 Citazioni (Scopus)

Abstract

Background A need for a governance of genomics in healthcare among European Union (EU) countries arose during an international meeting of experts on public health genomics (PHG). We have conducted a survey on existing national genomic policies in healthcare among Chief Medical Officers (CMOs) of the 28 EU member states, plus Norway. Methods A questionnaire was sent to CMOs after a meeting on the policy implications of PHG held during the Italian presidency of the Council of EU in 2014. The survey was closed in November 2015. Results CMOs response rate was 65.5% (19/29). Twelve (63.2%) reported that their countries had a policy for genomics in healthcare in place, and 15 (78.9%) reported that public funding existed. Public research facilities for the development of such policies were documented in 13 (68.4%) countries, and 15 (83.3%) had working groups devoted to policy development. National agencies carrying out Health Technology Assessment of genomic-based technologies were present in nine countries (50%). Sixteen (88.9%) countries reported having agencies dealing with ethical issues related to genomic technologies. About 55% of countries disclosed the lack of information campaigns aimed at citizens, and 44.4% reported they had a legal framework for direct-to-consumer genetic tests. Conclusion Belgium, France, Italy, Spain and UK documented the presence of a policy on genomics in healthcare. While many caveats are necessary because of the methodology, results suggest a need for a co-ordinated effort to foster development and harmonization of dedicated policies across EU to responsibly integrate genomics policies into existing health systems.
Lingua originaleEnglish
pagine (da-a)-
Numero di pagine7
RivistaEuropean Journal of Public Health
Stato di pubblicazionePublished - 2016

Fingerprint

European Union
Genomics
Delivery of Health Care
Public Health
Public Facilities
Technology
Biomedical Technology Assessment
Policy Making
Belgium
Norway
Surveys and Questionnaires
Ethics
Spain
Italy
France
Health
Research

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cita questo

Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers. / Mazzucco, Walter; Marotta, Claudia; Boccia, Stefania; Villari, Paolo; Colotto; Ricciardi, Walter; Mazzucco, Walter; Marzuillo, Carolina; Pastorino, Roberta; D'Andrea; Federici, Antonio; Lagerberg; Marotta.

In: European Journal of Public Health, 2016, pag. -.

Risultato della ricerca: Article

Mazzucco, W, Marotta, C, Boccia, S, Villari, P, Colotto, Ricciardi, W, Mazzucco, W, Marzuillo, C, Pastorino, R, D'Andrea, Federici, A, Lagerberg & Marotta 2016, 'Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers', European Journal of Public Health, pagg. -.
Mazzucco, Walter ; Marotta, Claudia ; Boccia, Stefania ; Villari, Paolo ; Colotto ; Ricciardi, Walter ; Mazzucco, Walter ; Marzuillo, Carolina ; Pastorino, Roberta ; D'Andrea ; Federici, Antonio ; Lagerberg ; Marotta. / Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers. In: European Journal of Public Health. 2016 ; pagg. -.
@article{87ccae50cb7c4952afd18a57322692c1,
title = "Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers",
abstract = "Background A need for a governance of genomics in healthcare among European Union (EU) countries arose during an international meeting of experts on public health genomics (PHG). We have conducted a survey on existing national genomic policies in healthcare among Chief Medical Officers (CMOs) of the 28 EU member states, plus Norway. Methods A questionnaire was sent to CMOs after a meeting on the policy implications of PHG held during the Italian presidency of the Council of EU in 2014. The survey was closed in November 2015. Results CMOs response rate was 65.5{\%} (19/29). Twelve (63.2{\%}) reported that their countries had a policy for genomics in healthcare in place, and 15 (78.9{\%}) reported that public funding existed. Public research facilities for the development of such policies were documented in 13 (68.4{\%}) countries, and 15 (83.3{\%}) had working groups devoted to policy development. National agencies carrying out Health Technology Assessment of genomic-based technologies were present in nine countries (50{\%}). Sixteen (88.9{\%}) countries reported having agencies dealing with ethical issues related to genomic technologies. About 55{\%} of countries disclosed the lack of information campaigns aimed at citizens, and 44.4{\%} reported they had a legal framework for direct-to-consumer genetic tests. Conclusion Belgium, France, Italy, Spain and UK documented the presence of a policy on genomics in healthcare. While many caveats are necessary because of the methodology, results suggest a need for a co-ordinated effort to foster development and harmonization of dedicated policies across EU to responsibly integrate genomics policies into existing health systems.",
author = "Walter Mazzucco and Claudia Marotta and Stefania Boccia and Paolo Villari and Colotto and Walter Ricciardi and Walter Mazzucco and Carolina Marzuillo and Roberta Pastorino and D'Andrea and Antonio Federici and Lagerberg and Marotta",
year = "2016",
language = "English",
pages = "--",
journal = "European Journal of Public Health",
issn = "1101-1262",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Current state of genomic policies in healthcare among European Union member states: results of a survey of chief medical officers

AU - Mazzucco, Walter

AU - Marotta, Claudia

AU - Boccia, Stefania

AU - Villari, Paolo

AU - Colotto, null

AU - Ricciardi, Walter

AU - Mazzucco, Walter

AU - Marzuillo, Carolina

AU - Pastorino, Roberta

AU - D'Andrea, null

AU - Federici, Antonio

AU - Lagerberg, null

AU - Marotta, null

PY - 2016

Y1 - 2016

N2 - Background A need for a governance of genomics in healthcare among European Union (EU) countries arose during an international meeting of experts on public health genomics (PHG). We have conducted a survey on existing national genomic policies in healthcare among Chief Medical Officers (CMOs) of the 28 EU member states, plus Norway. Methods A questionnaire was sent to CMOs after a meeting on the policy implications of PHG held during the Italian presidency of the Council of EU in 2014. The survey was closed in November 2015. Results CMOs response rate was 65.5% (19/29). Twelve (63.2%) reported that their countries had a policy for genomics in healthcare in place, and 15 (78.9%) reported that public funding existed. Public research facilities for the development of such policies were documented in 13 (68.4%) countries, and 15 (83.3%) had working groups devoted to policy development. National agencies carrying out Health Technology Assessment of genomic-based technologies were present in nine countries (50%). Sixteen (88.9%) countries reported having agencies dealing with ethical issues related to genomic technologies. About 55% of countries disclosed the lack of information campaigns aimed at citizens, and 44.4% reported they had a legal framework for direct-to-consumer genetic tests. Conclusion Belgium, France, Italy, Spain and UK documented the presence of a policy on genomics in healthcare. While many caveats are necessary because of the methodology, results suggest a need for a co-ordinated effort to foster development and harmonization of dedicated policies across EU to responsibly integrate genomics policies into existing health systems.

AB - Background A need for a governance of genomics in healthcare among European Union (EU) countries arose during an international meeting of experts on public health genomics (PHG). We have conducted a survey on existing national genomic policies in healthcare among Chief Medical Officers (CMOs) of the 28 EU member states, plus Norway. Methods A questionnaire was sent to CMOs after a meeting on the policy implications of PHG held during the Italian presidency of the Council of EU in 2014. The survey was closed in November 2015. Results CMOs response rate was 65.5% (19/29). Twelve (63.2%) reported that their countries had a policy for genomics in healthcare in place, and 15 (78.9%) reported that public funding existed. Public research facilities for the development of such policies were documented in 13 (68.4%) countries, and 15 (83.3%) had working groups devoted to policy development. National agencies carrying out Health Technology Assessment of genomic-based technologies were present in nine countries (50%). Sixteen (88.9%) countries reported having agencies dealing with ethical issues related to genomic technologies. About 55% of countries disclosed the lack of information campaigns aimed at citizens, and 44.4% reported they had a legal framework for direct-to-consumer genetic tests. Conclusion Belgium, France, Italy, Spain and UK documented the presence of a policy on genomics in healthcare. While many caveats are necessary because of the methodology, results suggest a need for a co-ordinated effort to foster development and harmonization of dedicated policies across EU to responsibly integrate genomics policies into existing health systems.

UR - http://hdl.handle.net/10447/218294

M3 - Article

SP - -

JO - European Journal of Public Health

JF - European Journal of Public Health

SN - 1101-1262

ER -